Skip to main content

False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency

  • Case Report
  • Chapter
  • First Online:
JIMD Reports, Volume 36

Part of the book series: JIMD Reports ((JIMD,volume 36))

Abstract

Classical galactosemia is detected through newborn screening by measuring galactose-1-phosphate uridylyltransferase (GALT) in the USA primarily via the Beutler spot assay. We report on an 18-month-old patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency that was originally diagnosed with classical galactosemia. The patient presented with elevated liver function enzymes and bilirubinemia and was immediately treated with soy-based formula. Confirmatory tests revealed deficiency of the GALT enzyme, however, full-sequencing of GALT was normal, suggestive of a different ideology. The Beutler spot assay uses three other enzymatic steps in addition to GALT. A deficiency in either of these enzymes can result in suspected decreased GALT activity when using the Beutler assay. Congenital Disorders of Glycosylation screening for phosphoglucomutase-1 deficiency was negative. Quantitative analysis of G6PD enzyme in red blood cells showed a severe deficiency and a deletion in G6PD. Soy-formula, the standard treatment for galactosemia, has been reported to trigger hemolysis in G6PD deficient patients. G6PD and phosphoglucomutase-1 deficiencies should be considered when confirmatory tests are negative for pathogenic variants in GALT and galactose-1-phosphate level is normal.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

6PGD:

6-Phosphogluconate dehydrogenase

ALT:

Alanine transaminase

AST:

Aspartate aminotransferase

CBC:

Complete blood count

CDG:

Congenital disorders of glycosylation

dl:

Deciliter

G6PD:

Glucose-6-phosphate dehydrogenase

Gal-1-P:

Galacose-1-phosphate

GALT:

Galactose-1-phosphate uridylyltransferase

Hb:

Hemoglobin

hr:

Hour

IU:

International unit

μmol:

Micromole

mg:

Milligram

ml:

Milliliter

NADP+ :

Nicotinamide adenine dinucleotide phosphate

NADPH:

Nicotinamide adenine dinucleotide phosphate

NBS:

Newborn screening

PGM1:

Phosphoglucomutase-1

U/g:

Units per gram

UDP-glucose:

Uridine diphosphate glucose

References

  • American College of Medical Genetics (2001) ACMG ACT sheets and confirmatory algorithms. Bethesda. http://www.ncbi.nlm.nih.gov/books/NBK55832/. Accessed 14 Nov 2016

  • Beutler E (1994) G6PD deficiency. Blood 84(11):3613–3636

    CAS  PubMed  Google Scholar 

  • Bosch AM (2006) Classical galactosaemia revisited. J Inherit Metab Dis 29(4):516–525

    Article  CAS  PubMed  Google Scholar 

  • Caprari P, Caforio MP, Cianciulli P et al (2001) 6-Phosphogluconate dehydrogenase deficiency in an Italian family. Ann Hematol 80(1):41–44

    Article  CAS  PubMed  Google Scholar 

  • Chevion M, Navok T, Glaser G, Mager J (1982) The chemistry of favism-inducing compounds. The properties of isouramil and divicine and their reaction with glutathione. Eur J Biochem 127(2):405–409

    Article  CAS  PubMed  Google Scholar 

  • Frank JF, Maj MC (2005) Diagnosis and management of G6PD deficiency. Am Fam Physician 72(7):1277–1282

    PubMed  Google Scholar 

  • Frazier PDM, Summer GK (1974) Automated fluorometric micromethod for detection of transferase-deficiency galactosemia. J Lab Clin Med 83(2):334–338

    CAS  PubMed  Google Scholar 

  • Fujimoto A, Okano Y, Miyagi T, Isshiki G, Oura T (2000) Quantitative Beutler test for newborn mass screening of galactosemia using a fluorometric microplate reader. Clin Chem 46(6):806–810

    CAS  PubMed  Google Scholar 

  • Li Y, Ptolemy AS, Harmonay L, Kellogg M, Berry GT (2010) Quantification of galactose-1-phosphate uridyltransferase enzyme activity by liquid chromatography–tandem mass spectrometry. Clin Chem 56(5):772–780

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ohlsson A, Guthenberg C, von Döbeln U (2011) Galactosemia screening with low false-positive recall rate: the Swedish experience. JIMD Rep 2:113–117

    Article  PubMed  PubMed Central  Google Scholar 

  • Pyhtila BM, Shaw KA, Neumann SE, Fridovich-Keil JL (2014a) A brief overview of galactosemia newborn screening in the United States. J Inherit Metab Dis 37(4):649–650

    Article  PubMed  Google Scholar 

  • Pyhtila BM, Shaw KA, Neumann SE, Fridovich-Keil JL (2014b) Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead. JIMD Rep 15:79–93

    PubMed  PubMed Central  Google Scholar 

  • Scott K, Gadomski T, Kozicz T, Morava E (2014) Congenital disorders of glycosylation: new defects and still counting. J Inherit Metab Dis 37(4):609–617

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Grace Stuhrman .

Editor information

Editors and Affiliations

Additional information

Communicated by: Daniela Karall

Appendices

Synopsis

Decreased GALT enzyme by Beutler spot assay can mask PGM1 or G6PD deficiencies and warrants further metabolic analysis in the absence of pathogenic variants in GALT. Soy-based formula intake can trigger hemolysis in G6PD deficiency.

Compliance with Ethics Guidelines

Conflict of Interest

Grace Stuhrman, Stefanie J. Perez Juanazo, Kea Crivelly, Jennifer Smith, Dr. Hans Andersson and Dr. Eva Morava declare that they have no conflicts of interest.

Informed Consent/Animal Rights

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). This article does not contain any studies with animal subjects performed by the any of the authors.

Details of the Contributions of Individual Authors

Grace Stuhrman drafted the initial manuscript and revised the manuscript.

Stefanie J. Perez Juanazo contributed to drafting the initial manuscript and conducted biochemical assays.

Jennifer Smith conducted biochemical assays.

Kea Crivelly, Eva Morava-Kozicz, and Hans Andersson critically reviewed and revised the manuscript.

All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Rights and permissions

Reprints and permissions

Copyright information

© 2017 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stuhrman, G., Perez Juanazo, S.J., Crivelly, K., Smith, J., Andersson, H., Morava, E. (2017). False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 36. JIMD Reports, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2016_34

Download citation

  • DOI: https://doi.org/10.1007/8904_2016_34

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-56137-9

  • Online ISBN: 978-3-662-56138-6

  • eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Publish with us

Policies and ethics